| AVY |
Report |
Adjusted diluted EPS |
BEAT |
pred $2.50 vs. cons $2.472 |
MEDIUM |
| AVY |
Report |
Net revenue |
IN-LINE |
pred $2.30B vs. cons $2.295B |
MEDIUM |
| AVY |
Report |
Organic growth |
BEAT |
pred 1.0% vs. cons 0.75% |
MEDIUM |
| AVY |
Guide |
Q3 adjusted EPS |
UNCHANGED |
guide midpoint $2.50 vs. cons $2.494 |
LOW |
| AVY |
Guide |
Q3 revenue |
UNCHANGED |
guide ~$2.31B vs. cons $2.319B |
LOW |
| AVY |
Guide |
2H Intelligent Labels |
UNCHANGED |
reaffirm 2H acceleration vs. cons UNVERIFIED |
LOW |
| AVY |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
LOW |
| AVY |
Return |
5-day cumulative residual |
+1.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — modest B-archetype confirmation |
LOW |